← All ETFs
Compare ETFs
4 funds side by side
How to read this: These ETFs report returns on different bases (Price Return, Total Return), so the return figures are not directly comparable. You are comparing an accumulating and a distributing ETF. Returns are shown as total return where available, so the distributing fund is not unfairly penalised for paying dividends out as cash.
Growth of €100, side by side
State Street® SPDR® S&P Emerging Markets Dividend ETF +39.8%iShares Core MSCI EM IMI UCITS ETF +73.9%State Street® SPDR® Portfolio Emerging Markets ETF +47.5%UBS Core MSCI EM UCITS ETF USD dis +58%
Each fund rebased to 100 at the start of the shared window — weekly closing prices, end-of-day. Past performance does not predict the future.
|
State Street® SPDR® S&P Emerging Markets Dividend ETF
SPDR
|
iShares Core MSCI EM IMI UCITS ETF
iShares
|
State Street® SPDR® Portfolio Emerging Markets ETF
SPDR
|
UBS Core MSCI EM UCITS ETF USD dis
UBS
|
|
|---|---|---|---|---|
| 1-yr return | +2.9% Price Return | +30.3% Total Return | +10.0% Price Return | +32.5% Total Return |
| TER (yearly cost) | 0.49% | 0.18% | 0.07% lowest cost | 0.15% |
| Dividends | Unknown | Reinvests dividends (accumulating) | Unknown | Pays you cash (distributing) |
| How it’s built | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) | Owns the shares (physical) |
| What it holds | Stocks (equity) | Stocks (equity) | Stocks (equity) | Stocks (equity) |
| Index | S&P Emerging Markets Dividend Opportunities Index | MSCI Emerging Markets IMI | S&P Emerging BMI Index | MSCI EM |
| Fund size | €1B | €38.9B | €15.6B | €11.3B |
| Home country (domicile) | US | IE | US | LU |
| Currency | USD | USD | USD | USD |
| Primary ticker | EDIV | EMIM | SPEM | UB32 |
| ISIN | US78463X5335 | IE00BKM4GZ66 | US78463X5095 | LU0480132876 |
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.